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The study examined whether abdominal obesity (AO) according to waist circumference was associated with more unfavourable
changes in other cardiometabolic risk (CMR) factors in sub-Saharan Africans. The study included 541 randomly selected and
apparently healthy subjects (50% women) aged 25–60 years. Complete data at baseline, 24, and 48 months later was available
in 366 subjects. AO was associated with higher CMR at baseline and over the follow-up period, except for high blood pressure. A
signiﬁcantlyhigherincidenceofhighratiooftotalcholesterol:HDL-cholesterol(TC/HDL-C)wasassociatedwithAO.Controlling
for WC changes, age, baseline diet, and lifestyles, the relative risk (RR) of low HDL-C and high TC/HDL-C was 3.2 (95% CI 1.06–
9.61) and 7.4 (95% CI 2.01–25.79), respectively, in AO men; the RR was not signiﬁcant in women. Over a four-year period, AO
therefore appeared associated with an adverse evolution of cholesterolemia in the study population.
1.Introduction
Obesity is an independent risk factor for chronic diseases,
such as diabetes, cardiovascular disease (CVD), and some
cancers [1, 2], which are the leading causes of deaths world-
wide [3]. According to the World Health Organization [4],
44% of diabetes, 23% of ischemic heart disease, and 7%
to 41% of some cancers are attributable to overweight and
obesity [3]. The rising incidence of chronic diseases asso-
ciated with obesity does not spare developing countries
(DCs) even low-income ones [5]. WHO estimates that if
appropriate preventive measures are not taken, 20 million
deaths by 2015 will be due to CVD and 80% of this mortality
burden will occur in DCs [6]. Changes in lifestyle and diet
that characterize the ongoing nutrition transition contribute
to the outbreak of obesity in DCs [7].
Abdominalobesity(AO)isamorepotentriskfactorthan
gynoid or general obesity [8]. Several studies have shown
thatAfricansandpeoplesofAfricandescenthavelessvisceral
fat than whites, regardless of gender, age, total body fat, and
BMI [9–12]. The prevalence of metabolic syndrome (MetS)
is reportedly lower among African Americans than in Cau-
casians [13] while the prevalence of CVD and insulin resis-
t a n c ei sh i g h e r[ 14, 15]. In a nested study of African descent
Haitians living in Montreal and white subjects paired for age,
sex, and BMI, Haitians had signiﬁcantly less visceral fat than
Whites for the same waist circumference (WC) [16]. In the
large INTERHEART study in 52 countries, the association
of myocardial infarction risk with abdominal obesity was
higher in Europeans than in Blacks [17] due to less visceral
fat in the latter than the former. The relationship between
obesity and other cardiometabolic risk (CMR) factors in
Africans is poorly documented. The prohibitive cost of
treatmentofobesity-relateddiseases,bothforthepatientand
the health system, mainly in developing countries, requires2 Journal of Obesity
that increased attention be paid to CMR assessment. The
challenge of addressing CMR factors is especially complex
in sub-Saharan settings where epidemiologic data related to
riskfactorsarenotreadilyorreliablyavailableatpresent.The
purpose of our study was to assess changes in CMR factors
in sub-Saharan Africans according to baseline obesity status
and taking account of diet and lifestyle. We hypothesized
that obesity as currently deﬁned by standard anthropometric
criteria is weakly associated with unfavourable changes of
other CMR factors.
2.Methods and Materials
2.1. Subjects and Study Design. This prospective observa-
tional study was conducted among Benin (West Africa)
adults who were initially in apparent good health. Subjects
(n = 541) aged 25–60 years were randomly selected by multi-
stage sampling and were enrolled in baseline study on CMR
factors and nutrition transition. Subjects were selected in
Cotonou, the largest urban city (n = 200), Ouidah, a small-
size city located 45km away from Cotonou (n = 171), and
the rural area surrounding Ouidah (n = 170) using location
data (urban) or after enumeration of compounds (semi-
urban and rural). Eligible participants were Beninese-born
subjects having lived in the study area for at least six months.
Subjects with a prior diagnosis of hypertension, diabetes or
cardiac condition were excluded, but those diagnosed for
high blood pressure or diabetes during the baseline study
or at followup remained in the cohort, whether or not they
received medical treatment. Details of sample size deter-
mination and sampling process were published elsewhere
[18,19].Afterthebaselinestudy(T0),subjectswerefollowed
up after 24 months (T1) and 48 months (T2). A ﬁnal sample
size of 350 was deemed suﬃcient to achieve 80% statistical
power with a signiﬁcance level (alpha) of 0.05 using logistic
regression on blood pressure as main dependent variable
[20].
2.2. Data Collection Procedure. Data were collected between
June2005 andOctober2010 by the sameinvestigator teamas
the baseline study. Only physicians collected anthropometric
data and measured blood pressure after standardization of
techniques. A laboratory technician handled the blood sam-
ples. Before each biochemical data collection, participants
were informed on the practical arrangements that were prior
to blood sampling: (1) an overnight fast of at least 12 hours,
(2) no alcohol for at least 48 hours, and (3) no intense
physical activity on the previous day. We made sure that
these conditions were met, otherwise another appointment
was set. Subjects were organized into self-help groups by area
of residence to facilitate followup and for active prevention
support once the followup study would be over. Apart
from contacts for formal followup data collection, self-help
groups were encouraged to meet every three months for
weight and blood pressure checks, and for standard general
health advice. Anthropometric and blood pressure data that
were collected during these meetings were not used in the
followup study reported here.
2.3. Study Variables
2.3.1. Anthropometric Parameters. Anthropometric variables
included body weight, height, and WC that were measured
according to standard procedures. WC was used as index
of abdominal obesity [21]. It was measured to the nearest
0.1cm at the midpoint between the lower rib margin and the
iliac crest while subjects were standing and breathing nor-
mally [21]. We used a ﬂexible nonstretch measuring tape at
baselinesurveyandattheﬁrstfollowup.Aﬂexiblenonstretch
measuring tape (Gulick) equipped with an estimator of the
applied tension during measurement was used in the last
followup. Two measures of WC were taken for each subject
and the mean of the two readings was used in the analyses.
Generic cutoﬀ values for AO (80 and 94cm for women and
men, resp.) were used, as recently recommended by several
organizations for sub-Saharan Africans, in the absence of
speciﬁc values [22]. Body weight was measured on subjects
in fasting with light clothing and without shoes to the
nearest 0.1kg using a mechanical scale that had maximum
capacity of 150kg (SECA, Germany). Height was measured
once at baseline to the nearest 0.1cm with a commercial
stadiometer (SECA, Germany). Body mass index (BMIs)
cutoﬀsf o ru n d e r w e i g h t( <18.5), overweight (25–29.9), and
obesity (≥30) were as deﬁned by WHO [23].
2.3.2. Blood Pressure. Blood pressure was measured using a
mercury sphygmomanometer. Systolic and diastolic blood
pressure was measured on the right arm of seated subjects
after a 10-minute rest. Two readings of systolic and diastolic
blood pressure were taken. The interval of time between the
ﬁrst and the second reading was at least 20 minutes [24].
The mean of the two readings was used in the analyses.
High blood pressure was deﬁned as systolic blood pressure
(SBP) ≥130mmHg and or diastolic blood pressure (DBP)
≥85mmHg [25].
2.3.3. Biochemical Parameters. Blood samples were collected
in the morning after a 12-hour overnight fast and were
centrifuged within two hours in the biochemistry labo-
ratory of the Institute of Applied Biomedical Sciences in
Cotonou. Using standard enzymatic laboratory methods,
fasting glycemia, and serum concentrations of total choles-
terol, HDL-cholesterol (HDL-C) and triglycerides were
determined.Theratiooftotalcholesterol/HDL-C(TC/HDL-
C) was computed. Abnormal values were deﬁned as: ele-
vated triglycerides (>1.70mmol/L); high fasting glycemia
(≥5.6mmol/L); and low HDL-cholesterol (≤1.29mmol/L in
women and ≤1.03mmol/L in men) [22]. Fasting insulin was
assayed using ELISA method with IBL kits (IBL, Hamburg).
Insulin resistance cutoﬀ was the 75th centile of HOMA-IR
(homeostasis model assessment, insulin resistance) in the
whole sample of subjects [26]. The selected cutoﬀsf o rh i g h
TC/HDL-C were 4 for men and 5 for women [27].
2.3.4. Cardiometabolic Risk Factors. CMR factors considered
in the study along with AO according to WC or high BMI
(overweight/obesity) were high blood pressure, high fasting
glycemia, insulin resistance (based on HOMA-IR), lowJournal of Obesity 3
HDL-C,highTC/HDL-C,andhightriglycerides.Incounting
CMR factors, high fasting glycemia or (newly diagnosed)
diabetes, or insulin resistance were considered as one risk
factor. Similarly, high blood pressure included medical treat-
ment for hypertension. Dyslipidemia as one risk factor was
deﬁned as low HDL-C, high TC/HDL-C, or high triglyceride
concentration.
2.3.5. Socioeconomic Variables. Socioeconomic data were
collected in personal interviews. Education and Socioeco-
nomic status (SES) were the main Socioeconomic factors
considered. SES was assessed at baseline using a household
amenity score as proxy of household income, much like in
several demographic and health surveys in Africa. The items
include type of latrine; paid domestic help; ownership of
land, motorcycle, car, television, mobile phone, land line
phone, and refrigerator; electricity, running water in the
house; type of fuelused forcooking; walland ﬂoor materials.
The SES score was computed separately in each site and
tertiles were used in analyses. Details of items and coding are
published elsewhere [18, 19].
2.3.6. Diet Quality. Dietary intake was computed at baseline
on the basis of two or three nonconsecutive 24-hour food
recalls conducted over an average period of one month. Diet
quality was appraised with several scores including a micro-
nutrient adequacy score which was signiﬁcantly associated
with CMR in the cross-sectional study (unpublished data)
and is therefore used in the present study. The micronutrient
score was based on adequacy of intake of 14 micronutrients
(vitamins A, B6, B12, C, and E, thiamine, riboﬂavin, niacin,
pantothenic acid, folic acid, magnesium, calcium, iron, and
zinc) according to WHO/FAO recommended dietary intakes
for age and sex [4].
2.3.7. Lifestyle Variables. Subjects were questioned at base-
line about their habitual drinking and smoking patterns.
Alcohol consumption is expressed in the present study as
mean quantity of pure alcohol per day. Regarding smoking,
we distinguished three categories: smokers, ex-smokers, and
nonsmokers. For alcohol and tobacco, the questionnaire was
based on the STEPwise tool developed by the WHO [28].
Baseline physical activity was assessed through two or
three nonconsecutive 24-hour recalls [18]. Participants were
asked about all their previous day’s activities, from the time
they got up to the moment they went to bed. Time spent
in bed, in various modes of transportation, for main and
secondary occupations, for house chores, and for leisure
activities was computed from the daily estimated schedule.
Theintensitylevelofeachactivitywasestimatedinmetabolic
equivalents (METS). Based on WHO guidelines for the pre-
vention of chronic diseases [29], we classiﬁed subjects
as active (≥3MET , ≥30min/day) and inactive (≥3MET ,
<30min or <3MET ,anyduration).
2.4. Statistical Analyses. Data were analyzed using SPSS,
version16.0(SPSSInc.,Chicago,IL).ThediﬀerencesinCMR
factors at baseline and at last followup according to anthro-
pometric status were assessed using chi2 test. The incidence
rate was computed as the number of new cases during the
four years divided by the number of subjects without the risk
factor at baseline. The relative (RR) risk of developing one
or the other CMR factor during the course of the followup
was assessed using multiple logistic regression models while
controlling for baseline age, diet (micronutrient intake
adequacy score), and lifestyle (alcohol consumption and
physical activity), as well as WC change between T0 and T2.
The level of statistical signiﬁcance for all tests was P = 0.05.
2.5. Ethical Considerations. The study was approved by the
Ethics Committee of the Faculty of Medicine (University of
Montreal) and by the Ministry of Health in Benin. Written
informed consent was obtained from each participant before
enrolment. The participants were all informed individually
of their blood pressure and the results of laboratory tests.
T h o s ew i t ha b n o r m a lv a l u e sw e r er e f e r r e dt oap h y s i c i a nf o r
diagnosis and treatment. The ﬁrst medical consultation and
prescription was paid by the research project.
3. Results
3.1. Study Subjects. Out of 622 eligible subjects, a total of
541 completed the study, giving a response rate of 86.9%.
The participation rates were 76.7% (415 out of 541) in ﬁrst
followup and 76.9% (416 out of 541) in the second followup;
67.7% (366 out of 541) had complete followup data.
Baseline characteristics of subjects who attended both
followups and those who missed one or the other (Table 1)
were not signiﬁcantly diﬀerent except for age, anthropomet-
ric status (in men only), and place of residence. Average age
was higher by roughly two years in men and women with
complete data compared to those with incomplete data. A
lower proportion of subjects were available for followup in
the large city than other locations. Obesity-related parame-
ters were signiﬁcantly higher in men with complete followup
than in those with incomplete data. Socioeconomic status,
diet, and lifestyle were not signiﬁcantly diﬀerent in the
two groups, however. Statistical analyses were performed on
subjects with complete data (n = 366) (Figure 1).
3.2. Baseline Obesity Status and Other Cardiometabolic Risk
Markers. At baseline, 39.3% of subjects with complete data
were overweight or obese according to BMI. AO reached
33.6%. Obesity was much more frequent in women than in
men. Indeed, one man for three women had AO. Similarly,
one man for two women was obese or overweight based on
BMI.
Table 2 gives the prevalence rate of CMR factors at
baseline according to anthropometric status of subjects.
Initial prevalence of CMR factors was generally higher in
obese or overweight subjects compared to those with normal
anthropometric status at onset of study, whether on the
basis of WC or BMI. The prevalence of hypertriglyceridemia
and fasting hyperglycemia was low and not signiﬁcantly
diﬀerent in obese and nonobese subjects. In AO subjects,
only 16.6% of women and 6.2% of men were free from
otherCMRfactors.Similarly,only19%ofwomenand13.6%4 Journal of Obesity
Table 1: Baseline characteristics of study subjects according to followup completion.
Characteristics Complete data
(n = 366)
Incomplete data
(n = 175) P valuea
Age years (mean ±SD)
Men 37.8 ±10.23 6 .0 ±9.9 0.041
Women 39.5 ±9.93 7 .0 ±10 0.007
Sex (%)
Men 48.6 53.1 0.326
Women 51.4 46.9
Location (%)
Large city 35.0 41.1
Small city 36.9 20.6 0.001
Rural area 28.1 38.3
Socioeconomic level (%)
Low 33.3 36.6
Medium 35.6 37.1 0.498
High 31.1 26.3
Education (%)
No formal education 24.8 26.8
Elementary school 34.9 33.7 0.880
High school and above 40.2 39.4
Physical activity (%)
Active (≥30min/d moderate/vigorous activity) 83.1 80.6
Inactive (<30min/d moderate/vigorous activity) 16.9 19.4 0.276
Alcohol consumption (%)
Binge drinking 8.2 8.0
Regular high 6.8 10.9
Regular moderate 35.5 33.7 0.462
None 49.5 47.7
Smoking (%)
Current smokers 4.4 4.0 0.539
Former smokers 7.7 5.1
Nonsmokers 88.0 90.9
Diet quality indicator (mean ±SD)
Micronutrient adequacy score 10.4 ±2.69 .9 ±2.7 0.706
Body mass index (mean ±SD)
Men 22.8 ±4.02 1 .2 ±3.1 <0.001
Women 25.8 ±5.82 6 .3 ±6.6 0.588
Waist circumference cm (mean ±SD)
Men 83.9 ±11.07 9 .0 ±8.0 0.001
Women 87.5 ±12.78 8 .0 ±14.4 0.993
Number of cardiometabolic risk factorsb 1.0 ±0.80 .9 ±0.9 0.706
aP value for unpaired t-test or χ2 test as appropriate.
bRisk factors other than abdominal obesity or overall overweight/obesity.
of men who were overweight/obese (BMI >25) at baseline
presented no additional CMR factor. In both men and
women, the proportion of subjects without any of the CMR
factors considered was signiﬁcantly higher in the nonobese
or overweight. The diﬀerence was particularly marked in
men, with at least a threefold increase in the proportion of
CMR-free subjects among the nonobese or overweight.
3.3. Four-Year Changes in Cardiometabolic Risk Factors.
Table 3 shows that the prevalence of most CMR factors
increased signiﬁcantly over the four-year followup in both
men and women, even hypertriglyceridemia which was low
and remained so. Of note, subjects who went on medical
treatment for high blood pressure (n = 30) are included in
the prevalence ﬁgures, and those being treated for diabetesJournal of Obesity 5
Baseline (T0)
(541)
Followup 1 (T1)
(415)
(416)
Complete dataa
(366)
Reasons for
Small city
171
Rural area
170
Large city
200
Participants: 151
Lost: 49
Participants: 143
Lost: 28
Participants: 121
Lost: 49
Participants: 132
Lost: 68
Participants: 155
Lost: 16
Participants: 129
Lost: 41
128
(50% women)
135
(49.6% women)
103
(55.3% women)
Enrolled: 541
(50% women)
Not found: 67
Refusals: 3
Deaths: 2
Not found: 36
Refusals: 0
Deaths: 0
Not found: 56
Refusals: 4
Deaths: 7
Eligible: 622
Refused: 81
noncompletion
Followup 2 (T2)
a: missing subjects in at least one followup are considered as having incomplete data
Figure 1: Study subjects.
with insulin or oral hypoglycemiants (n = 3) are included in
“high fasting glycemia” and “insulin resistance.” It is remind-
ed that at baseline, already diagnosed cases of hypertension
or diabetes were excluded from the cohort. There was over
the four-years a signiﬁcant decrease of high blood pressure
prevalence. The rate of general overweight/obesity tended
toincrease,andthatofAOincreasedsigniﬁcantly,butonlyin
women. In men, only an upward trend for overweight/obe-
sity was observed. Figure 2 provides more detail on the
evolution of BMI and WC status. In women, overall and ab-
dominal obesity increased signiﬁcantly. In men, overall obe-
sity and AO rates remained low over the followup period;
a nonsigniﬁcant upward trend was only observed for over-
weight, and not for overall obesity.
Compared to the nonobese, AO subjects exhibited
a signiﬁcantly higher incidence rate of high TC/HDL-C
(P = 0.002), as shown in Table 4. The incidence rate of insu-
lin resistance tended to be higher in AO subjects (P = 0.051).
Subjects who had to go onto medical treatment for high
blood pressure or diabetes are included in the incidence
ﬁgures. At the end of the followup period, the total number
of new cases was 81 for low HDL-C, 58 for high TC/HDL-
C, 83 for insulin resistance, 59 for high fasting glycemia, and
11 for diabetes, while there were 19 new cases of high blood
pressure, including the subjects under medical treatment
(data not shown).
In Table 5, the relative risk (RR) of onset of CMR factors
during the followup period according to obesity status is
shown separately for men and women, before and after
adjusting for WC changes, age, diet, and lifestyles. RR could
not be computed for other CMR factors because of too
small numbers. In women, the RR was not signiﬁcantly
higher in those with AO. In contrast, in men, the RR of
onset of dyslipidemia was three- to four-fold in subjects
exhibiting initial AO compared to the nonobese in the
nonadjusted model. Controlling for WC changes and initial
diet and lifestyle proﬁle further increased the likelihood of
dyslipidemia up to seven times.
4. Discussion
The study examined the evolution of cardiometabolic risk
(CMR) factors according to baseline obesity status, while
controlling for confounding factors, as well as for obesity
change over the followup period. We had to combine over-
weight and overall obesity (BMI ≥ 25) because of the small
number of men with overall obesity (BMI ≥ 30). Further-
more, results were examined primarily for AO using WC
cutoﬀs as suggested by several organizations (in an attempt
to harmonize the deﬁnition of MetS) in the absence of
speciﬁc values for sub-Saharan Africans [22], since AO is
considered to be associated with higher risk than general6 Journal of Obesity
Table 2: Baseline cardiometabolic risk factors according to anthropometric status (n = 366).
Risk factors (%) All
Abdominal obesity Overall overweight/obesity
Yes No P value Yes No P valuea
Women (n = 188) (n = 91) (n = 97) (n = 100) (n = 88)
High blood pressure 36.7 46.2 27.8 <0.001 44.0 28.4 0.026
High fasting glycemia 10.0 13.2 7.2 0.132 9.1 11.8 0.426
Insulin resistance 33.0 42.9 23.7 0.005 41.0 21.6 0.004
Low HDL-C 31.4 37.4 28.5 0.060 41.0 20.5 0.002
High TC/HDL-C 19.1 25.3 13.4 0.030 29.0 8.0 <0.001
High TG 1.1 1.1 1.0 0.732 1.0 1.1 0.718
No CMR factorb 28.2 16.6 39.2 <0.001 19 38.6 <0.001
Men (n = 178) (n = 32) (n = 146) (n = 44) (n = 134)
High blood pressure 35.1 65.6 28.8 <0.001 52.3 29.9 0.006
High fasting glycemia 7.9 12.5 6.8 0.228 6.7 11.4 0.243
Insulin resistance 19.1 34.4 15.8 0.015 36.4 13.4 <0.001
Low HDL-C 21.1 37.5 18.5 0.020 38.6 16.4 0.003
High TC/HDL-C 10.1 34.4 4.8 <0.001 29.5 3.7 <0.001
High TG 2.8 6.2 2.1 0.220 6.8 1.5 0.098
No CMR factorb 37.1 6.2 43.8 <0.001 13.6 44.8 <0.001
aP value for χ2 test.
bCardiometabolic risk factors (CMR) other than abdominal or overall overweight/obesity.
Table 3: Evolution of prevalence of cardiometabolic risk factors during the four-year followup period (n = 366).
Risk factors (%)
Women (n = 188) Men (n = 178)
Baseline T2 (4 years) P valuea Baseline T2 (4 years) P valuea
High blood pressureb 36.7 25.0 0.014 35.1 18.0 <0.001
High fasting glycemiac 10.1 17.0 0.050 7.9 23.6 <0.001
Insulin resistancec 33.0 38.2 0.281 19.1 29.2 0.025
Low HDL-C 31.4 47.3 <0.001 21.1 30.3 <0.001
High TC/HDL-C 19.1 29.1 0.022 10.1 18.0 0.032
High triglycerides 1.1 5.9 0.011 2.8 12.2 <0.001
Overweight/obesity 53.2 62.8 0.060 24.7 33.1 0.079
Abdominal obesity 48.4 68.1 <0.001 18.0 20.2 0.589
aP values for χ2 test.
bIncluding 30 subjects under treatment for high blood pressure.
cSubjects under treatment for diabetes are included (n = 3).
Table 4: Four-year incidencea rate of cardiometabolic risk factors according to baseline abdominal obesity status (n = 366).
Risk factors Overall incidence (%)
Speciﬁc incidence
Obese (%) Non obese (%) P valueb
High BPc 8.1 13.3 6.3 0.149
High fasting glycemiad 17.7 22.4 15.5 0.121
Diabetesd 3.0 4.9 2.1 0.236
Insulin resistanced 30.7 39.7 27.4 0.051
Low HDL-C 30.2 36.4 27.7 0.164
High TC/HDL-C 18.6 29.2 14.3 0.002
High triglyceride 8.4 10.8 7.1 0.229
aNumber of new cases divided by the total number of subjects without the risk factor at baseline.
bP-values for χ2 test.
cIncludes new cases under treatment for hypertension (n = 7).
dIncludes new cases under treatment for diabetes (n = 2).Journal of Obesity 7
Table 5: Onset of cardiometabolic risk factors over the followup period before and after adjusting for WC changes, age, diet, and lifestyle
(n = 366).
Not adjusted Adjusteda
Women Men Women Men
RR CI 95% RR CI 95% RR CI 95% RR CI 95%
High fasting glycemia 1.90 0.79–4.75 2.35 0.97–5.68 1.90 0.79–4.75 1.33 0.48–3.72
Insulin resistance 1.38 0.65–2.91 1.76 0.58–5.30 1.40 0.62–3.20 2.22 0.85–5.78
Low HDL-C 0.79 0.40–1.62 3.01 1.12–8.23 0.47 0.19–1.10 3.18 1.06–9.61
High TC/HDL-C 1.57 0.71–3.29 4.70 1.70–13.1 1.61 0.66–3.93 7.45 2.01–25.79
aAdjusted for WC (waist circumference) changes between T0 and T2 and baseline age, physical activity, alcohol intake, and dietary micronutrient adequacy
score.
Abdominal obesity
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Figure 2: Changes in obesity status over the four-year followup period (n = 366).
obesity [8]. However, we observed the same trends when
considering overweight/obesity based on BMI instead of AO
based on WC (data not shown). One practical implication
is that until speciﬁc cutoﬀ points for obesity (general or
abdominal) against chronic disease endpoints are validated
insub-SaharansAfricans,BMIcutoﬀforoverweightandWC
cutoﬀso f8 0c m( f o rw o m e n )a n d9 4c m( f o rm e n )f o rA O
might be used interchangeably for screening.
Only16.6%ofwomenwithabdominalobesityatbaseline
had no other CMR factor, and the proportion was still lower
among AO men (6.2%). It therefore proved impossible to
assess the evolution of uncomplicated obesity. Nonetheless,
we were able to verify whether baseline AO was associated
with a more adverse evolution of other CMR factors, at least
during a followup period of four years.
The CMR factors studied, except for the high TC/HDL-
C ratio, are usually examined together as the metabolic syn-
drome (MetS), which is a clustering of some of the following:
high blood pressure, dysglycemia, dyslipoproteinemia, and
abdominal obesity [22]. However, as we wanted to isolate
obesity and assess its impact on the evolution of other CMR
factors, we considered the risk factors separately. Another
justiﬁcation for not collapsing the CMR factors into the
MetS is that MetS phenotypes vary widely according to
race-ethnicity [16]. High triglyceride concentrations, for in-
stance, are not common among Africans while hypertension
is highly prevalent. In populations at risk for CVD, it was
reported that TC/HDL-C ratio would identify more at-risk
subjects than Framingham risk scores [30]. Furthermore,
TC/HDL-C showed the largest area under the curve of
HOMA-IR compared with other lipid components or ratios
in Indian diabetics [31]. We therefore also examined TC/
HDL-C.
Control variables were those found to be signiﬁcantly
associated with one or the other CMR factor in the baseline
study: age, physical activity, alcohol consumption, and die-
tary micronutrient adequacy as the only signiﬁcant diet
quality score [18, 19, 24, 32].
The study conﬁrmed that obesity, which is widespread
among women, was associated with elevated CMR in this
sub-Saharan population. Except for high blood pressure,
an upward trend of CMR markers was observed over the
four-year followup both in obese and non obese individuals.
The incidence of high TC/HDL-C was signiﬁcantly higher
in AO than nonobese subjects. The signiﬁcantly higher
relative risk of onset of dyslipoproteinemia in AO men (not
signiﬁcant in women) over the followup period, even in the
adjusted model, suggests that AO as currently deﬁned using8 Journal of Obesity
nonspeciﬁc cutoﬀs may be associated with higher CMR in
men than women. This is consistent with a recent cross-
sectional study in Senegal that reported less favourable CMR
proﬁles in men than women in general, with lower HDL-
C concentrations [33]. According to a recent review, higher
HDL-Cmaybeconsideredagender-speciﬁcprotectivefactor
in women [34]. However, longitudinal studies of longer
duration and in larger cohorts, using not only CMR factors
but also disease end points would be required to conﬁrm the
ﬁndings. Because of the small number of new cases of high
blood pressure and high hypertriglyceridemia, for instance,
we were unable to perform logistic regression on these risk
factors.
Thehigherobservedprevalenceofobesityamongwomen
than men is consistent with other studies in sub-Saharan
Africa [35]. This may be partly explained by the on-going
nutrition transition process in DCs with major shifts in diet
and lifestyle patterns under the inﬂuence of urbanization,
globalization, and economic growth [36, 37]. The observed
downward trend for WC among obese subjects, at least in
women, whereas the trend was positive in the nonobese, may
reﬂect this nutrition transition process, with normal subjects
progressively moving towards more abdominal adiposity;
or else, these opposite trends reﬂect the phenomenon of
regression to the mean.
In our study, the baseline proportion of insulin-resistant
subjectswassigniﬁcantlyhigherinobesecomparedwithnon
obese whereas no diﬀerence was observed for high fasting
glycemia. Furthermore, the incidence of hyperglycemia was
not diﬀerent in obese and non obese while the incidence of
insulin resistance tended to be higher in the obese. Indeed,
under normal conditions, the pancreatic islet β-cells increase
insulin release to overcome the reduced eﬃcacy of insulin
action, thereby maintaining normal glucose tolerance [38].
For obesity and insulin resistance to be associated with high
fasting glycemia, β-cells must be unable to compensate fully
fordecreasedinsulinsensitivity[39].Severalstudiesreported
the association of obesity and insulin resistance in obese
Africans based on BMI, waist/hip ratio, or WC [40–42].
However, the duration of obesity is reportedly critical [43,
44], but we did not have this information.
Low HDL-C was the most prevalent CMR factor in the
last followup, in both men and women (47.3% and 30.3%,
resp.). Concurrently, the incidence rate of high TC/HDL-C
was markedly higher in obese subjects. Triglycerides were
low and remained so irrespective of obesity status. This is
consistent with studies showing that low HDL-C is a major
dyslipoproteinemia phenotype in obese Africans [33, 45].
In fact, studies show a gradual decrease in HDL-C levels in
Africa, over the last three decades [45–47]. This decreasing
trend in HDL-C levels can be attributed to the urbanization
of African populations and changes in diet and physical
activity. As suggested by some authors, a longer life expect-
ancy and more access to abundant food may contribute to
increased prevalence of low HDL-C in developing countries
[48].
The downward trend of blood pressure means as ob-
served in our study over four years, even excluding subjects
under treatment for hypertension, cannot be fully explained,
although some authors reported a weak link between obesity
and high blood pressure in Africans [40, 49] while others
observed an association, for instance in rural communities
in south Nigeria [50]. Several cross-sectional studies in non-
Africans reported the deleterious eﬀect of obesity on blood
pressure [51, 52]. The etiologic mechanism linking obesity
and hypertension is the stimulation of sympathetic tone and
the activation of the renin-angiotensin-aldosterone system
mediated by adipocyte hormones [53]. Since Blacks had
less visceral fat, this relationship between obesity and blood
pressuremaybeweakerthaninCaucasians.Anotherpossible
explanation for the reduction of mean blood pressure during
the study is that individuals became more aware of their
blood pressure as it was checked in the self-help groups,
making them more receptive to the general health advice
given to them. However, when controlling for participation
in group meetings, the results were unchanged (data not
shown) so that self-help groups may not be considered as
confounders. Nevertheless, this does not exclude that sub-
jects adopted a more preventive diet and lifestyle, which
cannot be veriﬁed. We cannot totally exclude either technical
error measurements since blood pressure was not measured
by the same medical team throughout the study, although
measurement techniques were standardized.
Our study has some limitations. First, only 68% of base-
line participants had complete data and were included in the
analysis, since signiﬁcant diﬀerences in age, anthropometric
status (BMI and WC) and location were observed between
subjects lost to followup and those with complete followup
at T1 and T2. However, this reduction in sample size did not
aﬀect statistical power substantially. The small number of
obese men was nevertheless a limitation. Secondly, the rel-
atively short followup period did not allow collecting sufﬁ-
cient data on hard endpoints (incidence of diabetes, CVD, or
cancer) to fully assess the risk associated with obesity status.
Thirdly,wedidnothaveinformationonwhetherweightloss,
when it occurred, was intentional or not. Finally, the study
was only conducted in the southern part of Benin and there-
fore,extrapolationoftheﬁndingstootherpopulationgroups
requires caution. These limitations notwithstanding, the
study has major strengths, including that it is the ﬁrst pro-
spective population-based study in sub-Saharan Africa
which addresses the issue of cardiometabolic risk factor
changes according to AO. Additionally, we were able to con-
trol for several lifestyle variables in order to explore the inde-
pendent eﬀects of baseline AO status in men and women.
5. Conclusion
Abdominal obesity as deﬁned by high waist circumference
(generic cutoﬀs suggested for sub-Saharan Africans) was as-
sociated with higher CMR at baseline and over the four-year
followup period, except for high blood pressure, in initially
apparentlyhealthyBenin adults.Basedonourﬁndings, there
was a worsening trend of CMR factors during the followup
period among the abdominally obese subjects, and partic-
ularly for cholesterol proﬁle among men. These ﬁndings
support the need for obesity prevention measures. The lack
of association between baseline obesity and blood pressureJournal of Obesity 9
changes suggests that the eﬀect of obesity on the latter may
not be important in the study population. Larger longitudi-
nal studies of longer duration in sub-Saharan Africans are
needed to conﬁrm our ﬁndings.
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